CleanSpark
CLSK
MARA Holdings
MARA
Tesla
TSLA
Strategy
MSTR
Riot Platforms
RIOT
US Stock MarketDetailed Quotes
ITRM Iterum Therapeutics
- 1.4300
- -0.0100-0.69%
Close Mar 24 16:00 ET
- 1.4682
- +0.0382+2.67%
Post 20:01 ET
49.45MMarket Cap-1.13P/E (TTM)
1.5000High1.3700Low257.88KVolume1.4400Open1.4400Pre Close371.61KTurnover0.76%Turnover RatioLossP/E (Static)34.58MShares3.020052wk High-12.12P/B48.38MFloat Cap0.808052wk Low--Dividend TTM33.84MShs Float195.0000Historical High--Div YieldTTM9.03%Amplitude0.6010Historical Low1.4410Avg Price1Lot Size
Iterum Therapeutics News
Iterum Therapeutics Faces Commercialization Challenges for ORLYNVAH Despite FDA Approval
Iterum Therapeutics Highlights FDA Approval and Market Potential
Express News | Iterum Therapeutics PLC Files for Mixed Shelf of up to $150 Mln- SEC Filing
Earnings Call Summary | Iterum Therapeutics(ITRM.US) Q4 2024 Earnings Conference
Iterum Outlines ORLYNVAH's Market Potential With Exclusivity Through 2034
Iterum Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Adjusted EPS Results.
Iterum Therapeutics | 10-K: FY2024 Annual Report
Iterum Therapeutics Q4 24 Earnings Conference Call AT 8:30 AM ET
Iterum Therapeutics | 8-K: Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
Iterum Therapeutics Expects Its Available Cash To Be Sufficient To Fund Its Operations Into H2 Of 2025
Iterum Therapeutics 4Q Loss/Shr 25c >ITRM
Express News | Iterum Therapeutics Q4 Net Income USD -6.582 Million
Express News | Iterum Therapeutics Q4 Adjusted EPS USD -0.12
Express News | Iterum Therapeutics Q4 Operating Income USD -3.67 Million
Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
Earnings Scheduled For February 7, 2025
Earnings Preview: ITRM to Report Financial Results Pre-market on February 07
$Iterum Therapeutics(ITRM.US)$ is scheduled to release its financial results pre-market on February 07 ET. Earnings PreviewAnalysts estimate $Iterum Therapeutics(ITRM.US)$ to post revenue of USD0
Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Express News | Iterum Therapeutics PLC Files for Offering of up to $25 Mln of Ordinary Shares - SEC Filing
Market Insights
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.